You are here

Article Text

Article menu
Download PDFPDF
Prognosis
Age, impaired fasting glucose, and cirrhosis predicted mortality at mean 7.6 years for non-alcoholic fatty liver disease

https://doi.org/10.1136/ebm.11.1.26

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Adams LA, Lymp JF, St Sauver J, et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 2005;129:113–21.
    OpenUrlCrossRefPubMedWeb of Science

    
 
 Q What is the natural history of non-alcoholic fatty liver disease (NAFLD) in community based patients?

    Clinical impact ratings GP/FP/Primary care ★★★★★☆☆ IM/Ambulatory care ★★★★★☆☆ Gastroenterology ★★★★★☆☆

    METHODS

    Embedded ImageDesign:

    inception cohort followed for mean 7.6 years (range 0.1–23.5 y).

    Embedded ImageSetting:

    Olmsted County in southeastern Minnesota, USA.

    Embedded ImagePatients:

    435 patients (mean age 49 y, 51% women, 92% white) diagnosed with NAFLD, fatty liver, hepatic steatosis, steatohepatitis, or cryptogenic cirrhosis (confirmed by ultrasonography, computed tomography, or magnetic resonance imaging) between 1 January 1980 and 1 January 2000. Exclusion criteria included other liver disease, risk of viral hepatitis, secondary causes of fatty liver (medications, human immunodeficiency virus, or gastrointestinal bypass surgery), and average weekly ethanol consumption ⩾140 g.

    Embedded ImagePrognostic factors:

    age, sex, ethnicity, body mass index, average weekly alcohol intake, history of diabetes (fasting glucose ⩾126 mg/dl [6.93 mmol/l] or receiving treatment), impaired fasting glucose (IFG) (fasting glucose ⩾110 mg/dl [6.05 …

    View Full Text

    Footnotes

    • For correspondence: Dr P Angulo, Mayo Clinic, Rochester, MN, USA. angulohernandez.paul{at}mayo.edu

    • Source of funding: University of Western Australia.